Literature DB >> 19116444

Polarization of protective immunity induced by replication-incompetent adenovirus expressing glycoproteins of pseudorabies virus.

Young Woo Han1, Abi G Aleyas, Junu A George, Seon Ju Kim, Hye Kyung Kim, Hyun A Yoon, Dong Jin Yoo, Seong Ho Kang, Koanhoi Kim, Seong Kug Eo.   

Abstract

Replication-incompetent adenoviruses expressing three major glycoproteins (gB, gC, and gD) of pseudorabies virus (PrV) were constructed and used to examine the ability of these glycoproteins to induce protective immunity against a lethal challenge. Among three constructs, recombinant adenovirus expressing gB (rAd-gB) was found to induce the most potent immunity biased to Th1-type, as determined by the IgG isotype ratio and the profile of the Th1/Th2 cytokine production. Conversely, the gC-expressing adenovirus (rAd-gC) revealed Th2-type immunity and the gD-expressing adenovirus (rAd-gD) induced lower levels of IFN-? and IL-4 production than other constructs, except IL-2 production. Mucosal delivery of rAd-gB induced mucosal IgA and serum IgG responses and biased toward Th2-type immune responses. However, these effects were not observed in response to systemic delivery of rAd-gB. In addition, rAd-gB appeared to induce effective protective immunity against a virulent viral infection, regardless of whether it was administered via the muscular or systemic route. These results suggest that administration of replication-incompetent adenoviruses can induce different types of immunity depending on the expressed antigen and that recombinant adenoviruses expressing gB induced the most potent Th1-biased humoral and cellular immunity and provided effective protection against PrV infection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19116444      PMCID: PMC2679340          DOI: 10.3858/emm.2008.40.6.583

Source DB:  PubMed          Journal:  Exp Mol Med        ISSN: 1226-3613            Impact factor:   8.718


  38 in total

Review 1.  Nasal vaccines.

Authors:  S S Davis
Journal:  Adv Drug Deliv Rev       Date:  2001-09-23       Impact factor: 15.470

Review 2.  Recombinant viruses as tools to induce protective cellular immunity against infectious diseases.

Authors:  Carolina Damas Rocha; Braulia Costa Caetano; Alexandre Vieira Machado; Oscar Bruna-Romero
Journal:  Int Microbiol       Date:  2004-06       Impact factor: 2.479

3.  Protection induced by intramuscular immunization with DNA vaccines of pseudorabies in mice, rabbits and piglets.

Authors:  Wenzhou Hong; Shaobo Xiao; Rui Zhou; Liurong Fang; Qigai He; Bin Wu; Fuchun Zhou; Huanchun Chen
Journal:  Vaccine       Date:  2002-01-15       Impact factor: 3.641

Review 4.  Recombinant adenoviruses as vaccines.

Authors:  V Randrianarison-Jewtoukoff; M Perricaudet
Journal:  Biologicals       Date:  1995-06       Impact factor: 1.856

Review 5.  The use of DNA viruses as vectors for gene therapy.

Authors:  M Ali; N R Lemoine; C J Ring
Journal:  Gene Ther       Date:  1994-11       Impact factor: 5.250

Review 6.  DNA vaccination: antigen presentation and the induction of immunity.

Authors:  D J Shedlock; D B Weiner
Journal:  J Leukoc Biol       Date:  2000-12       Impact factor: 4.962

7.  Plasmid DNA is superior to viral vectors for direct gene transfer into adult mouse skeletal muscle.

Authors:  H L Davis; B A Demeneix; B Quantin; J Coulombe; R G Whalen
Journal:  Hum Gene Ther       Date:  1993-12       Impact factor: 5.695

8.  Vaccine-induced T cell-mediated immunity plays a critical role in early protection against pseudorabies virus (suid herpes virus type 1) infection in pigs.

Authors:  E M A van Rooij; M G M de Bruin; Y E de Visser; W G J Middel; W J A Boersma; A T J Bianchi
Journal:  Vet Immunol Immunopathol       Date:  2004-05       Impact factor: 2.046

Review 9.  The processing of antigens delivered as DNA vaccines.

Authors:  Mark Howarth; Tim Elliott
Journal:  Immunol Rev       Date:  2004-06       Impact factor: 12.988

10.  Protection of weaned pigs by vaccination with human adenovirus 5 recombinant viruses expressing the hemagglutinin and the nucleoprotein of H3N2 swine influenza virus.

Authors:  Ronald D Wesley; Min Tang; Kelly M Lager
Journal:  Vaccine       Date:  2004-09-03       Impact factor: 3.641

View more
  3 in total

1.  Modulation of protective immunity against herpes simplex virus via mucosal genetic co-transfer of DNA vaccine with beta2-adrenergic agonist.

Authors:  Seong Bum Kim; Young Woo Han; M M Rahman; Seon Ju Kim; Dong Jin Yoo; Seong Ho Kang; Koanhoi Kim; Seong Kug Eo
Journal:  Exp Mol Med       Date:  2009-11-30       Impact factor: 8.718

2.  Efficacy of a gB + gD-based subunit vaccine and the adjuvant granulocyte-macrophage colony stimulating factor for pseudorabies virus in rabbits.

Authors:  Zhi Cao; Ke Zhang; Heng Zhang; Hongliang Zhang; Ying Yu; Dehua Yin; Hu Shan; Zhihua Qin
Journal:  Front Microbiol       Date:  2022-08-03       Impact factor: 6.064

3.  A review of vaccine development and research for industry animals in Korea.

Authors:  Nak-Hyung Lee; Jung-Ah Lee; Seung-Yong Park; Chang-Seon Song; In-Soo Choi; Joong-Bok Lee
Journal:  Clin Exp Vaccine Res       Date:  2012-07-31
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.